Detalles de la búsqueda
1.
Force-sensing treadmill gait analysis system can detect gait abnormalities in haemophilia patients without arthropathy.
Haemophilia
; 30(3): 780-790, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38507270
2.
Coagulant potentials of emicizumab in the plasmas from infant and toddler patients with hemophilia A.
Pediatr Blood Cancer
; 70(10): e30590, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37467119
3.
Clinical conditions and risk factors for inhibitor-development in patients with haemophilia: A decade-long prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2).
Haemophilia
; 28(5): 745-759, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35689832
4.
Novel Insights and New Developments Regarding Coagulation Revealed by Studies of the Anti-Factor IXa (Activated Factor IX)/Factor X Bispecific Antibody, Emicizumab.
Arterioscler Thromb Vasc Biol
; 40(5): 1148-1154, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32237902
5.
A microchip flow-chamber assay screens congenital primary hemostasis disorders.
Pediatr Int
; 63(2): 160-167, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32640065
6.
[Risk factors of inhibitor development among hemophilia patients revealed in a 10-year prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2)].
Rinsho Ketsueki
; 62(7): 790-800, 2021.
Artículo
en Japonés
| MEDLINE | ID: mdl-34349064
7.
Assessment of self-/parent-reported quality of life in Japanese children with haemophilia using the Japanese version of KIDSCREEN-52.
Haemophilia
; 26(2): 243-250, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32090393
8.
Whole blood ristocetin-induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease.
Haemophilia
; 25(3): e174-e179, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30866149
9.
Emicizumab-mediated haemostatic function in patients with haemophilia A is down-regulated by activated protein C through inactivation of activated factor V.
Br J Haematol
; 183(2): 257-266, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30125997
10.
Factor (F)VIII/VIIa enhances global haemostatic function in the co-presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor.
Br J Haematol
; 181(4): 528-536, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29611182
11.
A case of moderate haemophilia A with inhibitor, carrying the p.R1800H mutation, complicated with juvenile idiopathic arthritis.
Haemophilia
; 25(1): e51-e54, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30507053
12.
Reduced plasma factor X is associated with a lack of response to recombinant activated factor VII in patients with hemophilia A and inhibitor, but does not impair emicizumab-driven hemostasis in vitro.
Thromb Res
; 237: 37-45, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547693
13.
Emicizumab-mediated hemostatic function assessed by thrombin generation assay in an in vitro model of factor VIII-depleted thrombophilia plasma.
Int J Hematol
; 119(2): 109-118, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38112996
14.
Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
Br J Haematol
; 163(1): 104-11, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23889549
15.
Decrease in in vivo coagulant potential of emicizumab in a patient with hemophilia A and inhibitor complicated with infectious mononucleosis.
Blood Coagul Fibrinolysis
; 34(2): 122-128, 2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36719809
16.
Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis.
Int J Hematol
; 118(6): 690-698, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37803190
17.
Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients.
Int J Hematol
; 115(4): 489-498, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35043383
18.
Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan.
Int J Hematol
; 115(2): 163-172, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34724152
19.
The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs.
Mol Ther Methods Clin Dev
; 27: 404-414, 2022 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36381300
20.
Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery.
Paediatr Anaesth
; 21(8): 865-71, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21251146